Conference
Does greater platelet inhibition explain abciximab's superiority in the TARGET trial? A randomized clinical comparison.
Authors
Swierkosz TA; Kapoor S; Tardiff DC; Hirshfeld JW; Klugherz BD; Kolansky DM; Magness K; Valettas N; Wilensky RL; Herrmann HC
Volume
104
Pagination
pp. 385-386
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
October 23, 2001
Conference proceedings
CIRCULATION
Issue
17
ISSN
0009-7322